Диссертация (1139704), страница 37
Текст из файла (страница 37)
155-60.145. Norby B., Nielsen H. V., Frimodt-Moller P. C. Transurethral interstitial lasercoagulation of the prostate and transurethral microwave thermotherapy vs transurethralresection or incision of the prostate: results of a randomized, controlled study in patientswith symptomatic benign prostatic hyperplasia // BJU Int. ‒ 2002. ‒ T. 90, № 9. ‒ C. 85362.- 233 -146. Muschter R., de la Rosette J. J., Whitfield H., Pellerin J. P., Madersbacher S.,Gillatt D.
Initial human clinical experience with diode laser interstitial treatment of benignprostatic hyperplasia // Urology. ‒ 1996. ‒ T. 48, № 2. ‒ C. 223-8.147. Hoffman R. M., MacDonald R., Slaton J. W., Wilt T. J. Laser prostatectomyversus transurethral resection for treating benign prostatic obstruction: a systematicreview // J Urol. ‒ 2003. ‒ T. 169, № 1.
‒ C. 210-5.148. Muschter R., Whitfield H. Interstitial laser therapy of benign prostatic hyperplasia// Eur Urol. ‒ 1999. ‒ T. 35, № 2. ‒ C. 147-54.149. Laguna M. P., Alivizatos G., De La Rosette J. J. Interstitial laser coagulationtreatment of benign prostatic hyperplasia: is it to be recommended? // J Endourol.
‒ 2003.‒ T. 17, № 8. ‒ C. 595-600.150. Muschter R. Free-beam and contact laser coagulation // J Endourol. ‒ 2003. ‒ T.17, № 8. ‒ C. 579-85.151. Daehlin L., Frugard J. Interstitial laser coagulation in the management of lowerurinary tract symptoms suggestive of bladder outlet obstruction from benign prostatichyperplasia: long-term follow-up // BJU Int. ‒ 2007. ‒ T. 100, № 1. ‒ C. 89-93.152. Bach T., Huck N., Wezel F., Hacker A., Gross A. J., Michel M. S. 70 vs 120 Wthulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment ofbenign prostatic hyperplasia: a systematic ex-vivo evaluation // BJU Int.
‒ 2010. ‒ T. 106,№ 3. ‒ C. 368-72.153. Seitz M., Bayer T., Ruszat R., Tilki D., Bachmann A., Gratzke C., Schlenker B.,Stief C., Sroka R., Reich O. Preliminary evaluation of a novel side-fire diode laseremitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: exvivo and in-vivo investigations // BJU Int. ‒ 2009. ‒ T. 103, № 6. ‒ C.
770-5.154. Hai M. A., Malek R. S. Photoselective vaporization of the prostate: initialexperience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia// J Endourol. ‒ 2003. ‒ T. 17, № 2. ‒ C. 93-6.155. McAllister W. J., Gilling P. J. Vaporization of the prostate // Curr Opin Urol. ‒2004. ‒ T. 14, № 1. ‒ C. 31-4.- 234 -156.
Wendt-Nordahl G., Huckele S., Honeck P., Alken P., Knoll T., Michel M. S.,Hacker A. Systematic evaluation of a recently introduced 2-microm continuous-wavethulium laser for vaporesection of the prostate // J Endourol. ‒ 2008. ‒ T. 22, № 5. ‒ C.1041-5.157. Heinrich E., Wendt-Nordahl G., Honeck P., Alken P., Knoll T., Michel M. S.,Hacker A. 120 W lithium triborate laser for photoselective vaporization of the prostate:comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model // JEndourol.
‒ 2010. ‒ T. 24, № 1. ‒ C. 75-9.158. Kuntzman R. S., Malek R. S., Barrett D. M. High-power potassium titanylphosphate laser vaporization prostatectomy // Mayo Clin Proc. ‒ 1998. ‒ T. 73, № 8. ‒ C.798-801.159. Ruszat R., Seitz M., Wyler S. F., Muller G., Rieken M., Bonkat G., Gasser T. C.,Reich O., Bachmann A. Prospective single-centre comparison of 120-W diode-pumpedsolid-state high-intensity system laser vaporization of the prostate and 200-W highintensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia //BJU Int. ‒ 2009. ‒ T.
104, № 6. ‒ C. 820-5.160. Bachmann A., Ruszat R. The KTP-(greenlight-) laser--principles and experiences// Minim Invasive Ther Allied Technol. ‒ 2007. ‒ T. 16, № 1. ‒ C. 5-10.161. Heinrich E., Schiefelbein F., Schoen G. Technique and short-term outcome ofgreen light laser (KTP, 80W) vaporisation of the prostate // Eur Urol. ‒ 2007. ‒ T. 52, №6. ‒ C. 1632-7.162. Hueber P. A., Liberman D., Ben-Zvi T., Woo H., Hai M. A., Te A. E., ChughtaiB., Lee R., Rutman M., Gonzalez R.
R., Barber N., Al-Hathal N., Al-Qaoud T., Trinh Q.D., Zorn K. C. 180 W vs 120 W lithium triborate photoselective vaporization of theprostate for benign prostatic hyperplasia: a global, multicenter comparative analysis ofperioperative treatment parameters // Urology. ‒ 2013. ‒ T. 82, № 5. ‒ C. 1108-13.163. Guo S., Muller G., Bonkat G., Puschel H., Gasser T., Bachmann A., Rieken M.GreenLight laser vs diode laser vaporization of the prostate: 3-year results of aprospective nonrandomized study // J Endourol. ‒ 2015.
‒ T. 29, № 4. ‒ C. 449-54.- 235 -164. Muller G., Bachmann A., Wyler S. F. Vaporization techniques for benign prostaticobstruction: GreenLight all the way? // Curr Opin Urol. ‒ 2014. ‒ T. 24, № 1. ‒ C. 42-8.165. Rieken M., Bonkat G., Muller G., Wyler S., Mundorff N. E., Puschel H., GasserT., Bachmann A. The effect of increased maximum power output on perioperative andearly postoperative outcome in photoselective vaporization of the prostate // Lasers SurgMed. ‒ 2013.
‒ T. 45, № 1. ‒ C. 28-33.166. Al-Ansari A., Younes N., Sampige V. P., Al-Rumaihi K., Ghafouri A., Gul T.,Shokeir A. A. GreenLight HPS 120-W laser vaporization versus transurethral resectionof the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trialwith midterm follow-up // Eur Urol. ‒ 2010. ‒ T.
58, № 3. ‒ C. 349-55.167. Horasanli K., Silay M. S., Altay B., Tanriverdi O., Sarica K., Miroglu C.Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethralresection of the prostate for prostates larger than 70 mL: a short-term prospectiverandomized trial // Urology. ‒ 2008. ‒ T. 71, № 2. ‒ C. 247-51.168. Alivizatos G., Skolarikos A., Chalikopoulos D., Papachristou C., Sopilidis O.,Dellis A., Kastriotis I., Deliveliotis C. Transurethral photoselective vaporization versustransvesical open enucleation for prostatic adenomas >80ml: 12-mo results of arandomized prospective study // Eur Urol.
‒ 2008. ‒ T. 54, № 2. ‒ C. 427-37.169. Bouchier-Hayes D. M., Anderson P., Van Appledorn S., Bugeja P., Costello A. J.KTP laser versus transurethral resection: early results of a randomized trial // J Endourol.‒ 2006. ‒ T. 20, № 8. ‒ C. 580-5.170. Ruszat R., Seitz M., Wyler S. F., Abe C., Rieken M., Reich O., Gasser T. C.,Bachmann A. GreenLight laser vaporization of the prostate: single-center experience andlong-term results after 500 procedures // Eur Urol. ‒ 2008. ‒ T. 54, № 4. ‒ C. 893-901.171.
Ruszat R., Wyler S. F., Seitz M., Lehmann K., Abe C., Bonkat G., Reich O.,Gasser T. C., Bachmann A. Comparison of potassium-titanyl-phosphate laservaporization of the prostate and transurethral resection of the prostate: update of aprospective non-randomized two-centre study // BJU Int. ‒ 2008.
‒ T. 102, № 10. ‒ C.1432-8; discussion 1438-9.- 236 -172. Gomez Sancha F., Bachmann A., Choi B. B., Tabatabaei S., Muir G. H.Photoselective vaporization of the prostate (GreenLight PV): lessons learnt after 3500procedures // Prostate Cancer Prostatic Dis. ‒ 2007. ‒ T. 10, № 4. ‒ C. 316-22.173. Malek R. S., Kuntzman R.
S., Barrett D. M. Photoselective potassium-titanylphosphate laser vaporization of the benign obstructive prostate: observations on longterm outcomes // J Urol. ‒ 2005. ‒ T. 174, № 4 Pt 1. ‒ C. 1344-8.174. Guo S., Muller G., Lehmann K., Talimi S., Bonkat G., Puschel H., Gasser T.,Bachmann A., Rieken M. The 80-W KTP GreenLight laser vaporization of the prostateversus transurethral resection of the prostate (TURP): adjusted analysis of 5-year resultsof a prospective non-randomized bi-center study // Lasers Med Sci.
‒ 2015. ‒ T. 30, № 3.‒ C. 1147-51.175. Hai M. A. Photoselective vaporization of prostate: five-year outcomes of entireclinic patient population // Urology. ‒ 2009. ‒ T. 73, № 4. ‒ C. 807-10.176. Rieken M., Bachmann A., Shariat S. F. Long-term follow-up data more than 5years after surgical management of benign prostate obstruction: who stands the test oftime? // Curr Opin Urol. ‒ 2016. ‒ T.
26, № 1. ‒ C. 22-7.177. Wezel F., Wendt-Nordahl G., Huck N., Bach T., Weiss C., Michel M. S., HackerA. New alternatives for laser vaporization of the prostate: experimental evaluation of a980-, 1,318- and 1,470-nm diode laser device // World J Urol. ‒ 2010. ‒ T. 28, № 2. ‒ C.181-6.178. Costello A. J., Agarwal D. K., Crowe H. R., Lynch W. J. Evaluation of interstitialdiode laser therapy for treatment of benign prostatic hyperplasia // Tech Urol. ‒ 1999.
‒T. 5, № 4. ‒ C. 202-6.179. Seitz M., Ruszat R., Bayer T., Tilki D., Bachmann A., Stief C., Sroka R., ReichO. Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potentialtreatment of benign prostatic enlargement // Lasers Med Sci. ‒ 2009. ‒ T. 24, № 3. ‒ C.419-24.180. Leonardi R. Preliminary results on selective light vaporization with the side-firing980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique //Prostate Cancer Prostatic Dis. ‒ 2009.
‒ T. 12, № 3. ‒ C. 277-80.- 237 -181. Erol A., Cam K., Tekin A., Memik O., Coban S., Ozer Y. High power diode laservaporization of the prostate: preliminary results for benign prostatic hyperplasia // J Urol.‒ 2009. ‒ T. 182, № 3. ‒ C. 1078-82.182. Seitz M., Sroka R., Gratzke C., Schlenker B., Steinbrecher V., Khoder W., TilkiD., Bachmann A., Stief C., Reich O. The diode laser: a novel side-firing approach forlaser vaporisation of the human prostate--immediate efficacy and 1-year follow-up // EurUrol. ‒ 2007. ‒ T. 52, № 6.
‒ C. 1717-22.183. Chiang P. H., Chen C. H., Kang C. H., Chuang Y. C. GreenLight HPS laser 120W versus diode laser 200-W vaporization of the prostate: comparative clinical experience// Lasers Surg Med. ‒ 2010. ‒ T. 42, № 7. ‒ C. 624-9.184. Chiang P. H., Chen C. H. Prostate vaporization in the treatment of benign prostatichyperplasia by using a 200-w high-intensity diode laser // Curr Urol Rep. ‒ 2010. ‒ T. 11,№ 4. ‒ C. 249-53.185. Chen C. H., Chiang P. H., Chuang Y. C., Lee W.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
